ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

IBRX ImmunityBio Inc

6.63
0.01 (0.15%)
プレマーケット
最終更新日: 21:39:51
15分遅延
名称 銘柄コード 市場 種別
ImmunityBio Inc IBRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.15% 6.63 21:39:51
始値 安値 高値 終値 前日終値
6.62
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1722:00BWConnecting the Dots of ANKTIVA’s Triangle Offense: A Deep..
2024/5/1006:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0721:00BWImmunityBio Completes GMP Drug Substance Manufacturing..
2024/5/0305:04BWImmunityBio, Serum Institute of India Agree on an Exclusive..
2024/4/3021:00BWImmunityBio Executive Chairman Dr. Patrick Soon-Shiong to..
2024/4/2513:03BWImmunityBio Announces Positive Overall Survival Results of..
2024/4/2310:56BWImmunityBio Announces FDA Approval of ANKTIVA®,..
2024/3/0623:00BWNIAID-Sponsored Study Shows N-803 Combined with Neutralizing..
2024/3/0523:00BWN-803 Combined with Natural Killer Cells Showed Potential to..
2024/2/2706:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2706:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2411:28EDGAR2Form 8-K - Current report
2024/2/2123:00BWImmunityBio Announces Full Accrual of First Two Phases of..
2024/2/0711:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0523:00BWImmunityBio Quality-of-Life Study in BCG-Unresponsive..
2024/2/0309:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0309:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0411:59EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/1/0411:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0411:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0220:08EDGAR2Form 8-K - Current report
2024/1/0220:00BWImmunityBio Announces $320 Million Investment by Oberland..
2023/11/1623:00BWImmunityBio to Participate in 35th Annual Piper Sandler..
2023/11/0911:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0723:00BWFirst Data for ImmunityBio’s Memory Cytokine-Enriched NK..
2023/10/2701:03DJNImmunityBio Shares Rally as FDA Accepts N-803 Resubmission
2023/10/2622:00BWFDA Accepts ImmunityBio’s BLA Resubmission as Complete and..
2023/10/2400:00DJNImmunityBio Shares 11% Higher on License Application..
2023/10/2322:00BWImmunityBio Announces Biological License Application..
2023/9/2819:06EDGAR2Form DEF 14C - Other definitive information statements
2023/9/2304:06EDGAR2Form D - Notice of Exempt Offering of Securities
2023/9/2205:25EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/9/1119:25EDGAR2Form 8-K - Current report
2023/9/1119:00BWImmunityBio Announces $470 Million Equity and Debt Financing..
2023/9/0708:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0708:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0121:30EDGAR2Form 8-K - Current report
2023/8/2918:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/2910:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2909:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2218:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/1618:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/1605:15EDGAR2Form 8-K - Current report
2023/8/1118:45PRNUSIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
2023/8/0918:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
2023/8/0905:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0418:45PRNUSIBRX SHAREHOLDER ALERT: Jakubowitz Law Reminds ImmunityBio..
2023/8/0322:00BWImmunityBio Names Enrique Diloné as Chief Technology Officer
2023/8/0218:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..

最近閲覧した銘柄

Delayed Upgrade Clock